OGX-225

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOGX-225
Drug Alias NameOGX-225
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin-like growth factor binding protein II inhibitorsInsulin-like growth factor binding protein V inhibitors
TargetsInsulin-like growth factor binding protein IIInsulin-like growth factor binding protein V
Therapy Area/IndicationsSolid tumoursProstatic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals IncOncogenex
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOncogenex
Active IndicationsN/A
Inactive IndicationsSolid tumoursProstatic NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A